Patents by Inventor Colin Glenn Begley

Colin Glenn Begley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating intracellular infection
    Patent number: 10500252
    Abstract: The present invention provides a method of treating an intracellular infection in a subject wherein the method comprising administering to the subject an IAP antagonist. In certain embodiments the IAP antagonist is a Smac mimetic.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: December 10, 2019
    Assignee: WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
    Inventors: Marc Pellegrini, Gregor Klaus-Peter Ebert, Colin Glenn Begley
  • Method of Treating Intracellular Infection
    Publication number: 20160143995
    Abstract: The present invention provides a method of treating an intracellular infection in a subject wherein the method comprising administering to the subject an IAP antagonist. In certain embodiments the IAP antagonist is a Smac mimetic.
    Type: Application
    Filed: June 25, 2014
    Publication date: May 26, 2016
    Inventors: Marc Pellegrini, Gregor Klaus-Peter Ebert, Colin Glenn Begley
  • Method of modulating fertility in animals
    Publication number: 20040043000
    Abstract: The present invention relates generally to a method for controlling fertility and/or modulating the maintenance of pregnancy in animals. The present invention further provides an animal model useful for screening for therapeutic agents to treat infertility, to prevent or reduce spontaneous abortion and/or as contraceptive agents in animals.
    Type: Application
    Filed: September 10, 2003
    Publication date: March 4, 2004
    Applicant: Amrad Operations, Pty. Ltd.
    Inventors: Lorraine Grace Robb, Harshal Hanumant Nandurkar, Colin Glenn Begley
  • Method of modulating fertility in animals by IL-11
    Patent number: 6669934
    Abstract: The present invention relates to a method for modulating fertility in an animal by administering an effective amount of IL-11 or derivatives or homologues thereof or an effective amount of an agonist or antagonist of the interaction between IL-11 and IL-11R&agr;.
    Type: Grant
    Filed: August 27, 1999
    Date of Patent: December 30, 2003
    Assignee: Amrad Operations, Pty. Ltd.
    Inventors: Lorraine Grace Robb, Harshal Hanumant Nandurkar, Colin Glenn Begley
  • Cytokines and their use in treatment and/or prophylaxis of breast cancer
    Publication number: 20020106347
    Abstract: The present invention relates generally to a method for the treatment or prophylaxis of animals including humans suffering from or predisposed to breast cancer or other related cancers which comprises the use of cytokines and/or functionally active derivatives, hybrids and/or analogs thereof and to pharmaceutical compositions comprising same as therapeutic agents. In particular, but not exclusively, the present invention is directed to the use of cytokines which are ligands of members of the haemopoietin receptor super family or their derivatives, hybrids or analogues as therapeutic agents. The present application also contemplates breast cancer therapies and methods of suppressing growth of normal breast cells or breast cancer cells by the use of one or more cytokines optionally in combination with other therapeutic agents as well as the use of agonists or antagonists of cytokine activity. Particularly preferred are oncostatin M (OSM) and leukemia inhibitory factor (LIF).
    Type: Application
    Filed: March 5, 2001
    Publication date: August 8, 2002
    Inventors: Andrea Margaret Douglas, Colin Glenn Begley